We hypothesized that a) patients in the AD continuum with higher BMI would exhibit higher plasma leptin concentration; b) a higher plasma leptin concentration would be related to higher regional neuroinflammation which was associated with the cognitive deterioration and/or NPS along the AD continuum. Here, LEP is linked to Alzheimer disease.